Paclitaxel and sirolimus coated balloons: create evidence before claims

Sponsored by B.Braun Melsungen AG

Facilitator: M. A. Rosli

Chatmaster: B. Scheller

Summary

Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons including first-in-man RCT results, and to share insights about the start of the RESPECT-ISR trial and the SCORE registry for the next generation of B. Braun's SeQuent drug coated balloons.

Learning Objectives

To join a controversial discussion about a sirolimus and paclitaxel coated balloon approach
To follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons including first-in-man RCT results
To share insights about the start of the RESPECT-ISR trial and the SCORE registry for the next generation of B. Braun's SeQuent drug coated balloons